📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-27 17:49
0 analysed today
FollowTelegram
0
Today
151,853
All-time analysed
43,533
Positive
6,742
Negative
92,741
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
5 announcements match the current filters (relevance ≥ 5).
Eyantra Ventures Q1 Revenue at ₹19.17 Cr; Posts Net Loss of ₹3.75 Cr
Eyantra Ventures reported consolidated revenue from operations of ₹19.17 crore for the quarter ended June 30, 2026, marking a 2.0% decline YoY from ₹19.56 crore and a 24.2% drop QoQ from ₹25.29 crore. The company posted a net loss of ₹3.75 crore compared to a profit of ₹6.78 crore in the preceding quarter and a loss of ₹3.43 crore in the year-ago period. Basic and diluted EPS for the quarter stood at ₹(9.44). Additionally, the board approved the strike-off of its non-functioning UAE subsidiary and is progressing with the NCLT merger of Prismberry Technologies.
Confidence: HIGH
What changedThe company swung back into a consolidated net loss of ₹3.75 crore in Q1 FY27 after a profitable Q4 FY26, alongside revenue contracting by 24.2% QoQ.
Why it mattersThe return to operational losses and top-line pressure continues the trend of profitability volatility, while the closure of the UAE subsidiary and merger of Prismberry streamline corporate structure.
Revenue from Operations (Q1): ₹19.17 crNet Loss (Q1): ₹3.75 crBasic EPS: ₹-9.44Merchandise Sales Revenue: ₹12.36 cr
📅 Short termWeak quarterly performance and sequential revenue contraction are likely to weigh negatively on near-term sentiment.
📈 Long termLong-term value creation depends on sustainable operating profit margins across services/merchandising and successful integration of merged subsidiaries.
⚠ Risk flags
- Persistent operational volatility with recurring quarterly losses
- Lack of segment-wise profitability disclosure by the CODM
Key Highlights
Consolidated revenue from operations stood at ₹19.17 crore (₹1,917.42 lakhs), down 24.2% QoQ
Net loss widened to ₹3.75 crore (₹374.95 lakhs) from a net profit of ₹6.78 crore in the prior quarter
Basic and diluted EPS contracted to ₹(9.44) against ₹33.78 in Q4 FY26
Sale of merchandise was the largest segment contributing ₹12.36 crore in revenue
NCLT approved the merger application for wholly owned subsidiary Prismberry Technologies
👀 What to Watch
Track the final NCLT approval and integration of Prismberry Technologies, alongside operational stabilization and margin turnaround in subsequent quarters.
Eyantra Ventures Posts Q1 Net Loss of ₹3.75 Cr; Revenue Down 24% QoQ to ₹19.17 Cr
Eyantra Ventures reported consolidated revenue from operations of ₹19.17 Cr (₹1,917.42 Lakhs) for the quarter ended June 30, 2026, down 24.2% QoQ compared to ₹25.29 Cr in the prior quarter. The company posted a net loss of ₹3.75 Cr (₹374.95 Lakhs), slipping back into the red from a net profit of ₹6.78 Cr in Q4 FY26. Diluted EPS stood at ₹(9.44). Additionally, the company is striking off its UAE subsidiary and has received NCLT clearance to proceed with the merger of Prismberry Technologies.
Confidence: HIGH
What changedEyantra Ventures returned to operational and net losses in Q1 FY27 following a temporary profitable quarter in Q4 FY26.
Why it mattersThe sequential earnings drop highlights persistent bottom-line volatility and pressure on core margins in its diversified operations.
Consolidated Revenue (Q1): ₹1,917.42 LakhsConsolidated Net Loss (Q1): ₹(374.95) LakhsDiluted EPS: ₹(9.44)Merchandise Revenue: ₹1,235.73 Lakhs
📅 Short termEarnings could pressure the stock price in the near term as top-line shrunk 24% QoQ and net profitability turned negative.
📈 Long termLong-term performance depends on operational turnaround, successful integration of merged subsidiaries, and scaling higher-margin IT service revenues.
⚠ Risk flags
- Continued quarterly net losses
- Sharp QoQ revenue decline
- Closure and impairment of foreign subsidiaries
Key Highlights
Consolidated revenue from operations fell 24.2% QoQ to ₹19.17 Cr (₹1,917.42 Lakhs) from ₹25.29 Cr in the prior quarter.
Swung to a consolidated net loss of ₹3.75 Cr (₹374.95 Lakhs) versus a net profit of ₹6.78 Cr in Q4 FY26.
Sale of merchandise was the largest segment at ₹12.36 Cr (₹1,235.73 Lakhs), followed by IT services at ₹5.06 Cr (₹506.35 Lakhs).
Board decided to close/strike off wholly owned subsidiary eYantra Ventures FZE, UAE.
👀 What to Watch
Track the completion of the Prismberry Technologies amalgamation and watch whether software and IT service revenue can drive margin stabilization in coming quarters.
Eyantra Ventures Q1 Revenue at ₹17.62 Cr; Net Loss of ₹0.08 Cr on UAE Subsidiary Write-off
Eyantra Ventures reported a 24% YoY increase in standalone revenue to ₹17.62 Cr for the quarter ended June 30, 2026. Despite revenue growth, the company posted a net loss of ₹0.086 Cr, primarily due to a ₹0.646 Cr exceptional charge for striking off its UAE subsidiary. Consolidated results were notably absent as a 51.92% subsidiary, Neuro and Spine Associates, failed to provide accounts following 'employee separations'. The company also received NCLT approval for the merger of Prismberry Technologies, which is not yet reflected in these financials.
Confidence: HIGH
What changedThe company transitioned from a profit to a loss this quarter due to a one-time write-off of its UAE operations and failed to meet consolidated reporting requirements.
Why it mattersThe inability to consolidate results due to subsidiary-level 'employee separations' indicates potential governance or operational risks in newly acquired entities, despite standalone revenue growth.
Revenue (Q1 FY27): ₹17.62 CrNet Loss (Q1 FY27): ₹0.086 CrExceptional Item (UAE Write-off): ₹0.646 CrRevenue vs TTM Revenue: ~26%Subsidiary Investment (Neuro & Spine): ₹10.80 Cr
📅 Short termThe stock may face pressure due to the reported loss and the lack of consolidated transparency for the quarter.
📈 Long termLong-term value depends on the successful integration of Prismberry Technologies and the turnaround of the healthcare investment, which currently faces reporting hurdles.
⚠ Risk flags
- Non-submission of consolidated results
- Operational issues at subsidiary (employee separations)
- Write-off of international operations
- High P/E ratio of 511.1 relative to low profitability
Key Highlights
Standalone revenue from operations increased 24% YoY to ₹17.62 Cr from ₹14.22 Cr.
Reported a net loss of ₹8.65 Lakhs for Q1 FY27 compared to a profit of ₹5.58 Lakhs in Q1 FY26.
Recognized an exceptional loss of ₹64.61 Lakhs for the impairment and credit loss related to eYantra Ventures FZE, UAE.
Invested ₹10.80 Cr to date in Neuro and Spine Associates Private Limited for a 51.92% stake.
NCLT Hyderabad approved the merger of Prismberry Technologies Pvt Ltd with an appointed date of April 1, 2026.
👀 What to Watch
Investors should monitor the eventual release of consolidated financial results and the operational stability of the healthcare subsidiary, Neuro and Spine Associates, following its reported internal issues.
Q1 Revenue up 24% to ₹17.62 Cr; Net Loss of ₹0.08 Cr due to UAE Subsidiary Write-off
Eyantra Ventures reported a 23.9% YoY increase in standalone revenue to ₹17.62 Cr for Q1 FY27. Despite revenue growth, the company posted a standalone net loss of ₹8.65 Lakhs, primarily due to a ₹64.61 Lakhs exceptional charge related to the closure of its UAE subsidiary. Consolidated results were notably delayed because a 51.92% subsidiary, Neuro and Spine Associates, failed to provide accounts citing employee separations. Additionally, the NCLT has approved the merger of Prismberry Technologies, which is not yet reflected in these financials.
Confidence: HIGH
What changedThe company transitioned from a small profit to a loss due to a one-time write-off of its UAE operations and faced a reporting delay for its consolidated accounts.
Why it mattersWhile revenue is growing, the company's margins remain extremely thin and the inability to consolidate accounts due to subsidiary-level 'employee separations' raises concerns regarding administrative oversight.
Revenue (Q1 FY27): ₹17.62 CrNet Loss (Q1 FY27): ₹0.086 CrExceptional Item (UAE Write-off): ₹0.646 CrInvestment in Neuro & Spine: ₹10.80 CrQ1 Revenue vs TTM Revenue: 25.9%
📅 Short termThe stock may face pressure due to the reported loss and the lack of consolidated visibility, which is critical given the company's recent investment activity.
📈 Long termThe long-term outlook depends on the successful integration of Prismberry Technologies and whether the company can improve its historically low operating margins (0.7% TTM).
⚠ Risk flags
- Delayed consolidated financial reporting
- Subsidiary-level operational instability (employee separations)
- Extremely high P/E ratio of 511.1
- One-off impairment of foreign subsidiary
Key Highlights
Standalone revenue increased to ₹17.62 Cr in Q1 FY27 from ₹14.22 Cr in Q1 FY26.
Recognized an exceptional loss of ₹64.61 Lakhs for the impairment and credit loss of eYantra Ventures FZE, UAE.
Reported a standalone net loss of ₹8.65 Lakhs versus a profit of ₹5.58 Lakhs in the year-ago period.
Invested ₹10.80 Cr to date for a 51.92% stake in Neuro and Spine Associates Private Limited.
NCLT Hyderabad approved the merger of wholly-owned subsidiary Prismberry Technologies on July 15, 2026.
👀 What to Watch
Investors should monitor the eventual release of consolidated financials to understand the performance of the ₹10.80 Cr investment in Neuro and Spine Associates and the impact of the Prismberry merger.
NCLT Approves First Motion for Merger of Prismberry Technologies with Eyantra Ventures
Eyantra Ventures has received NCLT approval for the first motion of its scheme of arrangement to merge its wholly-owned subsidiary, Prismberry Technologies, into the parent company. The NCLT has dispensed with the requirement for convening meetings of equity shareholders and creditors for both entities, significantly streamlining the merger timeline. As of March 31, 2026, Eyantra Ventures reported a net worth of ₹2,880.80 Lakhs, which the tribunal noted is far in excess of its liabilities. Since the transferor is a 100% subsidiary, no new shares will be issued, and the existing investment will be cancelled.
Confidence: HIGH
What changedThe NCLT has cleared the first major procedural hurdle for the merger by allowing the first motion application and waiving the need for stakeholder meetings.
Why it mattersThis merger simplifies the corporate structure by absorbing a 100% subsidiary, potentially reducing administrative overhead and consolidating the IT and software development capabilities of Prismberry directly into the listed entity.
Transferee Net Worth: ₹2,880.80 LakhsUnsecured Creditors (Eyantra): 139Paid-up Capital (Prismberry): ₹1,00,000Paid-up Capital (Eyantra): ₹2,00,68,750Order Date: July 15, 2026
📅 Short termThe stock may see neutral to slightly positive sentiment as the regulatory path for the merger is now clearer and faster due to the meeting dispensations.
📈 Long termThe merger represents a structural simplification; long-term value depends on how effectively the parent company utilizes Prismberry's software development and IT service capabilities.
Key Highlights
NCLT dispensed with meetings for 506 equity shareholders and 139 unsecured creditors of Eyantra Ventures.
Eyantra Ventures reported a positive net worth of ₹2,880.80 Lakhs as of March 31, 2026.
Prismberry Technologies has a paid-up share capital of ₹1,00,000, which will be cancelled upon merger completion.
The merger involves zero share issuance as Prismberry is a wholly-owned subsidiary.
The scheme was approved by the Board of Directors on May 25, 2026.
👀 What to Watch
Investors should watch for the filing of the second motion petition and the final NCLT order, which will determine the effective date of the merger and the formal integration of Prismberry's IT services into Eyantra.
